| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 07/15/2008 | US7399760 1-(4-Methylsulfanyl-phenyl)-6-phenyl-pyrimidin-2,4-(1H)-dione;cyclooxygenase and prostaglandin inhibitor; tumor necrosis factor and interleukins 1, 6, 8, 12 antagonist; |
| 07/15/2008 | US7399537 Organic electroluminescence device and phenylenediamine derivative |
| 07/15/2008 | US7399505 Nematic or cholesteric or chiral-smectic; high absolute values of dielectric anisotropy combined with a favorable ratio of viscosity to clearing point; light- and UV-stable, and also thermally stable; high voltage holding ratio |
| 07/15/2008 | CA2275400C Process for the preparation of substituted pyrimidine desrivatives |
| 07/15/2008 | CA2144473C Pna synthesis using a base-labile amino protecting group |
| 07/14/2008 | CA2675265A1 Process for the preparation of ethyl-n-(2, 3-dichloro-6-nitrobenzyl) glycine hydrochloride |
| 07/10/2008 | WO2008083280A1 Compounds and methods of treating insulin resistance and cardiomyopathy |
| 07/10/2008 | WO2008083101A1 Phosphoramidate alkylator prodrugs for the treatment of cancer |
| 07/10/2008 | WO2008080965A2 Hiv inhibiting 5,6-substituted pyrimidines |
| 07/10/2008 | WO2008080964A1 Hiv inhibiting 6-substituted pyrimidines |
| 07/10/2008 | US20080167464 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 07/10/2008 | US20080167330 Anticancer agents |
| 07/10/2008 | US20080167329 3,4-Dihydroquinazolin-2(1H)-ones, e.g., 4-Ethyl-6-chloro-4-phenyl-3-(2,2,2-trifluoroethyl)-3,4-dihydroquinazolin-2(1H)-one; treatment of epilepsy, pain, movement disorders, cognitive disorders, psychological disorders, sleep disorders, hot flashes, fibromyalgia, and drug withdrawl |
| 07/10/2008 | US20080167328 Antitumor agents |
| 07/10/2008 | US20080167327 Crystalline, formed by crystallizing from an aqueous solution without agitation; treating cancer |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167308 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
| 07/10/2008 | US20080167307 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof |
| 07/10/2008 | US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors |
| 07/10/2008 | US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 07/10/2008 | US20080166358 Quinazoline derivatives and methods of treatment |
| 07/10/2008 | CA2674185A1 Hiv inhibiting 5,6-substituted pyrimidines |
| 07/10/2008 | CA2674178A1 Hiv inhibiting 6-substituted pyrimidines |
| 07/09/2008 | EP1942105A1 Aminodihydrothiazine derivative |
| 07/09/2008 | EP1940827A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/09/2008 | EP1940826A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/09/2008 | EP1940814A1 Piperazine derivatives as antimalarial agents |
| 07/09/2008 | EP1940804A2 Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 07/09/2008 | EP1940407A2 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
| 07/09/2008 | EP1768978B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 07/09/2008 | CN101218211A Quinoxaline derivatives as antitumor agents |
| 07/09/2008 | CN101218210A Processes for the manufacture of rosuvastatin and intermediates |
| 07/09/2008 | CN101215264A Method for synthesizing pyrimidinamine |
| 07/09/2008 | CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/09/2008 | CN100400107C Drugs for diagnosis of tissue-reproductive activity or treatment of proliferative disease |
| 07/08/2008 | US7396927 Process for preparation of rosuvastatin calcium |
| 07/08/2008 | US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases |
| 07/08/2008 | US7396836 Pyrimidine compound and medicinal composition thereof |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/03/2008 | WO2008079907A1 Compositions and methods for inhibition of the jak pathway |
| 07/03/2008 | WO2008079719A1 Pyrimidine kinase inhibitors |
| 07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
| 07/03/2008 | WO2008077885A2 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer |
| 07/03/2008 | WO2008077548A1 Pyrimidyl derivatives as protein kinase inhibitors |
| 07/03/2008 | WO2008077507A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
| 07/03/2008 | WO2008077453A1 5-fluorouracil derivatives and their use for the treatment of cancer |
| 07/03/2008 | WO2008077188A1 Bicyclic pyrimidinones and uses thereof |
| 07/03/2008 | WO2008061208A3 Arylsulfonamide compounds |
| 07/03/2008 | WO2008061208A2 Arylsulfonamide compounds |
| 07/03/2008 | WO2008053334A3 An improved process for preparing rosuvastatin calcium |
| 07/03/2008 | WO2008043835A3 Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2h)-pyrimidinyl]-4-fluoro-n-[[methyl-(1-methyl-ethyl)amino]sulphonyl]benzamide |
| 07/03/2008 | WO2007039112A8 Novel phloroglucinol derivatives having selectin ligand activity |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161561 Reacting N-[4-(2,2-Dimethyl-propionylamino)-5-(3,4,5-trimethoxy-benzyl)-pyrimidin-2-yl]-2,2-dimethyl-propionamide with an indole to produce 3-[4-(2,4-Bis-isobutyrylamino-pyrimidin-5-ylmethyl)-6,7-dimethoxy-benzofuran-2-carbonyl]-5-chloro-1-(toluene-4-sulfonyl)-1H-indole-2-carboxylicacid-dimethylamide |
| 07/03/2008 | US20080161560 Reacting N-[4-(4-flurophenyl)-5-formyl-6-isopropylpyrimidin-2-yl]-N-methylmethylsulfonamide with (carbethoxymethylene)triphenylphosphorane producing the correct absolute stereochemistry at C-5 (S) of Rosuvastatin side chain followed by regioselective chain extension |
| 07/03/2008 | US20080161322 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161297 Rho kinase inhibitors |
| 07/03/2008 | CA2673466A1 Substituted tetracycline compounds |
| 07/03/2008 | CA2673184A1 New compounds |
| 07/03/2008 | CA2673183A1 Bicyclic pyrimidinones and uses thereof |
| 07/03/2008 | CA2673003A1 Quinazolines for pdk1 inhibition |
| 07/03/2008 | CA2672718A1 Pyrimidyl derivatives as protein kinase inhibitors |
| 07/03/2008 | CA2672564A1 Substituted heteroaryl pyridopyrimidone derivatives |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/03/2008 | CA2670645A1 Pyrimidine kinase inhibitors |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939187A1 Substituted heteroaryl pyridopyrimidone derivatives |
| 07/02/2008 | EP1939186A1 5-Fluorouracil derivatives and their use for the treatment of cancer |
| 07/02/2008 | EP1939185A1 New types of hetaryl-phenylendiamin-pyrimidines as protein kinase inhibitors for the treatment of cancer |
| 07/02/2008 | EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase |
| 07/02/2008 | EP1937672A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 07/02/2008 | EP1937653A1 Pyrimidine derivatives and their use as kcnq potassium channels openers |
| 07/02/2008 | EP1937652A1 Pyrimidine amide compounds as pgds inhibitors |
| 07/02/2008 | EP1937237A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 07/02/2008 | EP1730117A4 Thiourea compositions and uses thereof |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | CN101213180A Method for producing dihydroquinazolines |
| 07/02/2008 | CN101213179A 2,4-diamino-pyrimidines used as Aurora inhibitors |
| 07/02/2008 | CN101212969A Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 07/02/2008 | CN101212903A Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
| 07/02/2008 | CN101209997A Pyrimidine-4-formic acid esters and synthetic method thereof |
| 07/02/2008 | CN100398543C Method of preparing fugutoxin water extract |
| 07/02/2008 | CN100398524C Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 07/02/2008 | CN100398523C 2,4-dichlor phenoxyacetic amide pyrimidine derivative and its preparation method and agricultural composition |
| 07/02/2008 | CN100398518C Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters |
| 07/02/2008 | CN100398206C Catalyst for producing ethyoxyl quinoline |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 07/01/2008 | US7393855 Treating human herpes virus, human immunodeficiency virus, and hepatitis B virus; optionally administered with other antiviral agents; (E)-9-{[2,2-bis-(hydroxymethyl)cyclopropylidene]methyl}adenine |
| 07/01/2008 | US7393367 Containing a 3-allyl-4-hydroxybenzaldehyde; quaternary (thi)oxopyrmidinium salt; hetero(carbonyl)acetonitrile (2-cyanomethylbenzimidazole); excellent brilliance and depth of color; wide range of color nuances; improved fastness |
| 06/26/2008 | WO2008076949A2 Quinazoline derivatives and methods of treatment |
| 06/26/2008 | WO2008076778A1 4-amino-1h-pyrimidin-2-one based compounds, compositions comprising them, and methods of their use |
| 06/26/2008 | WO2008075353A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | WO2008075341A1 Process for the preparation of substituted cynophenoxy-pyrimidinyloxy-phenyl acrylate derivatives |
| 06/26/2008 | WO2008074578A2 Agent for dyeing fibers comprising keratin |
| 06/26/2008 | WO2008074515A1 Novel hetaryl-phenylene-diamine pyrimidine as protein kinase inhibitors |
| 06/26/2008 | WO2008074445A1 Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof |
| 06/26/2008 | WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents |